when to take semaglutide oral For patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor Benefits of Semaglutide GLP-1 Injections

"Biochemistry, Tetrahydrofolate"

Patients with pre-existing diabetic retinopathy, particularly those on insulin, should be monitored closely as rapid improvement in glycaemic control has been associated with temporary worsening of diabetic retinopathy

~33.3% of users lost 10% or more body weight ~9.5% of users lost 15% or more body weight Common side effects Side effects include but are not limited to nausea, heartburn, hypoglycemia, constipation, and diarrhea, among others

Response rates vary by molecule newer agents such as tirzepatide and semaglutide yield higher responder rates (~86%91%) than older agents such as exenatide or liraglutide (~40%65%) (223) and vary by baseline BMI, sex, and glycemic status, with women and individuals with higher BMI responding better (222, 224)